KDM3A-mediated SP1 activates PFKFB4 transcription to promote aerobic glycolysis in osteosarcoma and augment tumor development

W Wang, B Wang - BMC cancer, 2022 - Springer
Background Lysine-specific histone demethylase 3A (KDM3A) is a potent histone modifier
that is frequently implicated in the progression of several malignancies. However, its role in …

Loss of NSUN6 inhibits osteosarcoma progression by downregulating EEF1A2 expression and activation of Akt/mTOR signaling pathway via m5C methylation

S Hu, M Yang, K Xiao, Z Yang… - Experimental and …, 2023 - spandidos-publications.com
As an important 5‑methylcytidine (m 5 C) methyltransferase, NOP2/Sun RNA
methyltransferase family member 6 (NSUN6) has been reported to play an important role in …

[HTML][HTML] Long noncoding RNA KCNQ1 opposite strand/antisense transcript 1 promotes osteosarcoma progression through miR-154-3p/KLF12

Q Zhang, H Jiang, Y Jin, N Zhang, Z Mu… - American journal of …, 2021 - ncbi.nlm.nih.gov
Objective: Osteosarcoma (OS) is a common bone cancer that usually influences children.
Metastasis and recurrence are the main reasons for the poor prognosis. In this study, we …

METTL3 stabilizes HDAC5 mRNA in an m6A-dependent manner to facilitate malignant proliferation of osteosarcoma cells

R Jiang, Z Dai, J Wu, S Ji, Y Sun, W Yang - Cell death discovery, 2022 - nature.com
Osteosarcoma (OS) is a prevalent primary bone sarcoma. Methyltransferase-like 3
(METTL3) is dysregulated in human malignancies. This study explored the mechanism of …

YTHDF1 upregulation mediates hypoxia-dependent breast cancer growth and metastasis through regulating PKM2 to affect glycolysis

X Yao, W Li, L Li, M Li, Y Zhao, D Fang, X Zeng… - Cell death & …, 2022 - nature.com
N6-methyladenosine modification is the most common RNA modification mechanism in
mammals. YTHDF1, a m6A reader, can recognize the m6A of mRNAs to facilitate the …

N6-Methyladenosine RNA Demethylase FTO Promotes Gastric Cancer Metastasis by Down-Regulating the m6A Methylation of ITGB1

D Wang, X Qu, W Lu, Y Wang, Y Jin, K Hou… - Frontiers in …, 2021 - frontiersin.org
Abnormal RNA m6A methylation is known to lead to the occurrence and progression of
multiple cancers including gastric cancer (GC). However, the integrative effects of all m6A …

RNA m6A Methyltransferase METTL3 Promotes The Growth Of Prostate Cancer By Regulating Hedgehog Pathway

J Cai, F Yang, H Zhan, J Situ, W Li, Y Mao… - OncoTargets and …, 2019 - Taylor & Francis
Purpose N6-methyladenosine (m6A) is the most abundant internal modification on
eukaryotic mRNA and gained increasing attention recently. More and more evidence …

LINC00968 functions as an oncogene in osteosarcoma by activating the PI3K/AKT/mTOR signaling

G Liu, D Yuan, P Sun, W Liu, PF Wu… - Journal of cellular …, 2018 - Wiley Online Library
Osteosarcoma is recognized as a malignant tumor in the skeletal system. Long non‐coding
RNAs (lncRNAs) have been exhibited to play crucial roles in osteosarcoma development …

Analysis and identification of m6A RNA methylation regulators in metastatic osteosarcoma

H Huang, X Cui, X Qin, K Li, G Yan, D Lu… - … Therapy-Nucleic Acids, 2022 - cell.com
Osteosarcoma (OS) is characterized by rapid growth and early metastasis. However, its
mechanism remains unclear. N 6-methyladenosine (m 6 A) modification and its regulatory …

ZBTB7C m6A modification incurred by METTL3 aberration promotes osteosarcoma progression

X An, W Wu, L Yang, J Dong, B Liu, J Guo, J Chen… - Translational …, 2023 - Elsevier
Abstract Aberrant N6-methyladenosine (m6A) modification of mRNAs contributes
significantly to the epigenetic tumorigenesis, however, its precise role and the key targets in …